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Abstract
Influenza virus infection remains a public health problem worldwide. The mechanisms underlying viral control during an
uncomplicated influenza virus infection are not fully understood. Here, we developed a mathematical model including both
innate and adaptive immune responses to study the within-host dynamics of equine influenza virus infection in horses. By
comparing modeling predictions with both interferon and viral kinetic data, we examined the relative roles of target cell
availability, and innate and adaptive immune responses in controlling the virus. Our results show that the rapid and
substantial viral decline (about 2 to 4 logs within 1 day) after the peak can be explained by the killing of infected cells
mediated by interferon activated cells, such as natural killer cells, during the innate immune response. After the viral load
declines to a lower level, the loss of interferon-induced antiviral effect and an increased availability of target cells due to loss
of the antiviral state can explain the observed short phase of viral plateau in which the viral level remains unchanged or
even experiences a minor second peak in some animals. An adaptive immune response is needed in our model to explain
the eventual viral clearance. This study provides a quantitative understanding of the biological factors that can explain the
viral and interferon kinetics during a typical influenza virus infection.
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Introduction
Despite vaccines and antiviral agents, influenza A virus infection
remains a major public health problem worldwide. Seasonal and
pandemic influenza results in approximately 3 to 5 million cases of
severe illness and approximately 250,000 to 500,000 deaths
worldwide [1]. Influenza viruses primarily infect and replicate in
epithelial cells [2]. The immune response to influenza virus
infection plays an important role in controlling the virus within a
host. The nonspecific innate immune response provides the first
line of defense, which reacts immediately upon infection and
involves generating a variety of chemotactic, proinflammatory and
antiviral cytokines [3]. An important cytokine produced during the
innate immune response is type I interferon (mainly IFN-a/b).
IFN-a/b has been shown to stimulate resistance to infection in the
neighboring cells by inducing the expression of many IFN-
stimulated gene products, including antiviral proteins, such as
protein kinase R, PKR [4]. Depletion of key IFN signaling
proteins in mice results in greater mortality, accompanied by
systemic (as opposed to respiratory-restricted) infection [5]. In
addition, IFN is able to activate immune system cells, such as
natural killer (NK) cells, during the early stage of infection, which
can destroy infected cells [6–10]. The secretion of IFN-a/b by
infected epithelial cells is also important for the initiation of the
antigen-specific adaptive immune response [11,12], which in mice
takes approximately 5 days to begin in the lung [13]. The adaptive
immune response mainly consists of cytotoxic CD8
+ T cells
eliminating infected cells and antibodies neutralizing the virus
[11]. It is important for clearing the virus and provides immunity
against future influenza virus infections. Because of limited
information about influenza pathogenesis and the host immune
response in humans, various animal models, such as mice, ferrets,
and horses [14–17], have been used to obtain a better
understanding of the biological mechanisms underlying viral
control.
A number of mathematical models have been developed to
study the dynamics of influenza virus infection and immune
responses [13,18–28] (also see recent reviews in [29–31]). By fitting
a simple viral dynamic model to the data derived from 6
experimentally infected human volunteers, Baccam et al. [20]
showed that target cell limitation can explain the kinetics of
influenza A virus infection in humans. Both innate [18,20,28] and
adaptive immune responses [21,22,24] have also been incorpo-
rated into the basic model to evaluate the effect of immune
responses on viral control. In a recent study, Miao et al. [13]
quantitatively investigated the innate and adaptive immune
responses to primary influenza A virus infection in mice. They
compared the half-life of infected epithelial cells and free virus
before and during a virus-specific immune response (about 5 days
post-infection). Lee et al. [27] developed a two-compartment
model to study the contributions of different factors, such as
antigen presentation and activation of naive T and B cells, CD4
+
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+ mediated cytotoxicity, and antibody, to the
control of influenza A virus infection. These studies provide a
quantitative understanding of the host immune response in
controlling virus replication.
The relative contributions of target cell availability and immune
responses to viral control remain unclear. In a recent study, Saenz
et al. [19] estimated the numbers of viral-antigen-positive cells in
the lungs of ponies at days 2.5, 4.5, and 5.5 after challenge with
equine influenza virus (EIV). The result indicated that up to 5% of
bronchiole cells were infected at any one time, yielding an
estimated total cell loss of about 27% by the end of the infection.
This suggests mechanisms for viral control in addition to target cell
depletion [20], and motivates the development of a model that
includes a strong innate immune response to explain the clearance
of virus during infection [19]. However, the model in [19] is
unable to capture a number of important features of the viral
kinetics observed in 6 ponies, e.g., the viral peak in most of the
ponies, the rapid and substantial viral decline after the peak (2 to 4
log decline within 1 day), and a short plateau phase in which the
viral load remained unchanged or even experienced a minor
second peak in some ponies [19]. In this study, we develop
mathematical models based on several possible biological mech-
anisms that attempt to explain all of these observations. Our
objective is to investigate which biological parameters can give rise
to the viral load change observed during an uncomplicated
influenza virus infection.
Materials and Methods
Experimental data
The data we studied were from an experimental challenge of 6
unvaccinated ponies infected with EIV A/eq/Kildare/89 (H3N8)
[16]. Nasal secretions (NS) were collected daily for 10 days post-
challenge and number of copies of influenza virus RNA per
milliliter (ml) was quantified. Blood samples were also collected to
quantify the fold changes in cytokine expression including IFN for
days 1 through 5 post-challenge compared to the day prior to
challenge. We used both the viral load and the IFN fold change
data in this study. High antibody titers were detected by the single
radial haemolysis (SRH) assay 14 days post-challenge in the
horses.
Upon infection, the viral load increased rapidly and reached its
peak at day 2 for all ponies. There was a wide variation in the peak
level. The highest was approximately 10
8 copies of viral RNA/ml
of NS (pony 2), while the lowest was 10
4 copies/ml of NS (pony 6).
After the peak, the viral load experienced a rapid and substantial
decline (about 2 to 4 logs within 1 day). All the ponies had a viral
plateau and some experienced a minor but obvious second peak.
After the viral plateau/second peak, there was a second viral
decline starting around day 6. In 4 out of the 6 ponies, the viral
load decreased to below the detection limit by day 8. The rest of
the ponies had undetectable viral load at day 9. During the
infection, IFN expression increased substantially reaching a peak
on day 2 in 5 of the 6 ponies, followed by a rapid decrease to the
pre-infection level [16,19]. The peak of IFN-fold change ranged
from approximately 1 (pony 3) to more than 10 (pony 6).
Mathematical model
We developed a model to study the within-host dynamics of
EIV infection in horses. It is described by the following system of
equations
dT
dt
~{bVT{wFTzrR
dI
dt
~bVT{dI{kIF
dR
dt
~wFT{rR
dV
dt
~pI{cV
dF
dt
~qI{dF
ð1Þ
The model has five variables: target cells (T), productively infected
cells (I), uninfected cells that are refractory to infections (R) because
of IFN-induced antiviral effect [32], free virus (V), and IFN (F).
The term bVT represents the rate of infection when virus
encounters susceptible target cells. IFN induces an antiviral effect
and enables uninfected cells to become refractory to infection at
rate wFT. Cells in the refractory state revert back to the susceptible
state at rate r. Infected cells are assumed to die at per capita rate
d.
Prior to the emergence of the antigen-specific adaptive immune
response, we assume d is a constant dI. This rate (d) becomes
dA=dm-(dm-dI)e
2s(t-m) after the adaptive immune response emerg-
es, where m is the time at which the adaptive immune response
emerges, dm is the maximum death rate of infected cells in the
presence of an adaptive immune response, and s determines how
fast the death rate increases from dI to the saturation rate dm.
Because we only model the dynamics for a few days after the
adaptive immune response emerges, we modify the time-varying
death rate to dA=dIe
s(t-m) without using the maximum constant dm.
In this way, the number of parameters introduced is reduced by 1.
Another method that explicitly includes the adaptive immune
response as an additional variable in the model was also examined
and the results are mentioned in the Discussion section.
In the early stage of influenza virus infection, NK cells can be
activated by IFN to induce cytolysis of infected epithelial cells and
play an important role in the innate immune response [6,7,8,9,10].
Here, we assume the number of activated NK cells is proportional
to the level of IFN and use the mass action term kIF to represent
the killing by NK cells. Note that killing by NK cells is an
important, but not the only factor leading to the loss of infected
cells. Cytokines or proteins released by other cells such as
macrophages [33] during the innate immune response can also
Author Summary
Influenza, commonly referred to as the flu, is a contagious
respiratory illness caused by influenza virus infections.
Although most infected subjects with intact immune
systems are able to clear the virus without developing
serious flu complications, the mechanisms underlying viral
control are not fully understood. In this paper, we address
this question by developing mathematical models that
include both innate and adaptive immune responses, and
fitting them to experimental data from horses infected
with equine influenza virus. We find that the innate
immune response, such as natural killer cell-mediated
infected cell killing and interferon’s antiviral effect, can
explain the first rapid viral decline and subsequent second
peak viremia, and that the adaptive immune response is
needed to eventually clear the virus. This study improves
our understanding of influenza virus dynamics and may
provide more information for future research in influenza
pathogenesis, treatment, and vaccination.
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virus infection [34,35]. Infected cells are assumed to produce virus
at rate p and free virus is cleared at rate c per virion. As in the
previous models by Baccam et al. [20] and Saenz et al. [19], loss of
virions due to infection has been neglected. Since an infected cell
may produce as many as 20,000 virions [36], the loss of one virion
to produce an infected cell can be neglected. IFN is secreted by
infected cells at rate q and decays at rate d. A schematic diagram of
Eq. (1) is shown in Figure 1. Variables and parameters are
summarized in Table 1.
Parameter values and data fitting
We fixed some parameters and estimated the rest by fitting the
model to both the viral load and IFN data. The lifespan of infected
cells prior to the emergence of the adaptive immune response, 1/
dI, was fixed to 0.5 days [31,37], which is the value used in
previous modeling studies [19,21]. Because no CD8
+ T cell data
were obtained in this experiment, we chose the time at which the
adaptive immune response emerges (m) according to the second
viral decline. For example, we chose m=7 days for pony 1 and
m=6 days for pony 2. A similar method has been used previously
in analyzing acute HCV infection kinetics in chimpanzees [38].
We also included a delayed adaptive immune response explicitly in
the model and obtained similar results (see Discussion). The initial
population of epithelial cells in the equine respiratory tract was
fixed at T0=3.5610
11 cells [39]. We assume all such cells are
target cells, as used in Saenz et al. [19], although H3N8 viruses
prefer to infect a 2,3 sialic acid glycan-expressing cells [40] and
thus the number of target cells could be less than assumed here.
We include sensitivity test to a number of parameters including the
initial number of target cells below. We set the initial population of
infected cells and refractory cells to 0, and the initial IFN fold
change to 1, i.e., no change, as given in the data set. The
remaining parameters were estimated from data fitting. Note that
some parameters, such as the infection rate constant b and the
viral production rate p, do not have physiological values because
they are in the unit of ml of nasal secretions.
We fit the model to both the viral load and IFN data of each
pony using the commercial software package Berkeley Madonna
(Version 8.3.18). The obtained parameter values were based on
the best nonlinear least squares fit of the model equations to the
data set, i.e., the program minimized the root mean square (RMS)
between data points and the corresponding model predictions,
given by
RMS~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1
nV
X nV
i~1
logVi{log V Vi ðÞ
2z
1
nF
X nF
i~1
Fi{ F Fi ðÞ
2
v u u t ð2Þ
where the number of viral load and IFN fold change measure-
ments for an individual pony are denoted by nV and nF,
respectively. Viral load data is given by  V Vi and the analogous
value given by our model is Vi. Similarly, the measured IFN fold
change is  F Fi and the corresponding model prediction is Fi. The
first data point below the detection limit (100 copies/ml of NS) was
assumed to be 1 copy/ml of NS. Other values, such as half of the
detection limit, can also be used [41], which will affect the estimate
of the parameter s in this study. There are also other approaches
to incorporating left-censored measurements [42]. We did not
include the viral load data under the detection limit after the first
undetectable data point. Equal weights for both viral titer and IFN
data were employed because they are approximately in the same
range. Using different weights or normalized data (each value is
divided by the maximum) generates a similar fit, although the
estimates of parameter values can be different.
Approximation of viral decline after the peak using the
target cell limited model
The target cell limited model was used in [20] and described by
the following equations: dT/dt=2bVT, dI/dt=bVT-dI, and dV/
dt=pI-cV. Assuming tpeak is the time at which the viral load
achieves its peak, we have pI=cV at t=t peak. Thus, I(tpeak)=cV
(tpeak)/p. Because target cells are nearly depleted around the peak
Figure 1. Schematic representation of Eq. (1).
doi:10.1371/journal.pcbi.1002588.g001
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period after tpeak, and solved for I(t). This assumption was also used
in [23] to obtain an approximation for the decay after the peak
using the model with an eclipse phase. The solution is
I(t)~
c
p
Vpeake{d(t{tpeak), t§tpeak. Substituting this into the V(t)
equation and solving for V(t), we have V(t)~Vpeake{c(t{tpeak)z
cVpeak
c{d
½e{d(t{tpeak){e{c(t{tpeak) , t§tpeak. Thus, the predicted viral
load reduction 1 day after the peak is
V(tpeakz1)
Vpeak
~e{cz
c
c{d
(e{d{e{c)~
c
c{d
e{d{
d
c{d
e{c.A sc is typically much
larger than d (Table 2), this ratio is mainly determined by the value
of d . For d in the range of (0, 4.5) day
21, which covers most of the
estimates in the literature [20], the ratio is always greater than 0.01
for any positive value of c. This implies that for any value of d,4.5
day
21, the target cell limited model generates ,2 log decline within
1 day after the peak. The actual viral load reduction predicted by
the model should be less than this approximation because we
assumed T<0 over the interval [tpeak, tpeak+1]. Numerical results
show that to obtain a 3 log decline within 1 day after the peak, c
should be .12 day
21 and d needs to be .8 day
21. To attaina 4 log
decline, c should be .18 day
21 and d needs to be .10 day
21.
Statistical analysis
To statistically compare the best fits using model 1 (Eq. (1)) and
model 2 (setting k to 0 in model 1, i.e., no killing of infected cells
by NK cells), we performed an F-test. An F-test is used to compare
two nested models used to fit the same data set to determine
whether the model with more parameters statistically improves the
fit. The improvement is considered to be statistically significant if
the p-value is less than 0.05. We begin with the calculation of the
F-value as follows:
F~
½RSS2{RSS1 =½df2{df1 
RSS1=df1
,
whereRSSisthesumofsquaredresidualsbetweenmodelpredictions
and data. The RMS value generated from Berkeley Madonna is the
root of the mean squared residuals. Hence, RSS=nN(RMS)
2, where n
is the number of data points. The subscripts 1 and 2 represent model
1 and model 2, respectively. The degree of freedom associated with
RSS isdf=n-m,wh er em isthe numberof fittedparameters.Note that
m, the time at which the adaptive immune response emerges, was
counted as a fitted parameter although we fixed it according to the
second viral decline. To compute the p-value, we calculated the F
distribution evaluated at the F-value with (df2-df1, df1) degrees of
freedom. Comparison between models was performed individually
for all the ponies.
Results
Overview of the best fits of Eq. (1) to experimental data
We fit the predicted values of V(t) and F(t) in Eq. (1) to the viral
load and IFN (fold change) kinetic data, respectively, of each pony.
The best fits, shown in Figures 2 (red solid) and 3 (blue solid),
indicate that Eq. (1) agrees with both the viral load and IFN data
well. Parameter values corresponding to the best fits are given in
Table 2. Note that the estimates of some parameters, such as the
infection rate b and the viral production rate p, have large
variations. This is expected because there is a large variation (up to
4 logs) in the peak viral load of the 6 ponies. We also fit the model
to the average data of the 6 ponies (Figures 2 and 3). The average
data show similar kinetic changes of viral titer and IFN, and the
best-fit model agrees well with the data.
For comparison, we also plotted the best fits (dashed lines in
Figures 2 and 3) of the Saenz et al. model [19] to the same viral
load and IFN data. Our model improves the viral load data fits in
several aspects. First, our fits capture the viral peak in all 6 ponies.
Second, the fits achieve the rapid and substantial viral decline
within 1 day after the peak in all ponies. Third, the fits generate a
period of viral plateau and/or a second peak. Lastly, our fits
generate the rapid second viral decline to below the detection limit
in all 6 ponies. Detailed explanations and possible biological
mechanisms for these viral load changes are given below.
Table 1. Variables, parameters, and values used in Eq. (1).
Symbol Definition Unit Value
T Uninfected epithelial cells that are susceptible to infection cells initial value: 3.5610
11
[39]
I Infected epithelial cells cells initial value: 0
R Epithelial cells in the refractory state cells initial value: 0
V Viral load RNA copies (ml NS)
21 initial value: fitted
F Interferon IFN fold change initial value: 1
b Infection rate (RNA copy)
21 ml NS day
21 fitted
w IFN-induced antiviral efficacy (IFN fold change)
21 day
21 fitted
r Reversion rate from refractory day
21 fitted
dI Death rate of infected cells before the adaptive immune response emerges day
21 2 [31,37]
dA Time-varying death rate of infected cells during the adaptive immune response day
21 see text
k Killing rate of infected cells by NK cells (IFN fold change)
21 day
21 fitted
p Viral production rate RNA copies (ml NS)
21 day
21 cell
21 fitted
c Clearance rate of free virions day
21 fitted
q Production rate of IFN IFN fold change day
21 cell
21 fitted
d Decay rate of IFN day
21 fitted
doi:10.1371/journal.pcbi.1002588.t001
Within-Host Dynamics of Influenza Infection
PLoS Computational Biology | www.ploscompbiol.org 4 June 2012 | Volume 8 | Issue 6 | e1002588Rapid and substantial viral decline after the peak
The viral loads in all 6 ponies experienced a 2 to 4 log decline
within 1 day after the peak [16,19]. Similar viral declines were also
observed in 6 volunteers experimentally infected with influenza A
virus [20]. What causes such a rapid and substantial viral decline
within a short period of time? The data fits using both the target
cell limited model in [20] and the modified model in [19] did not
capture this feature. In fact, using the target cell limited model we
can derive an approximation of the viral load reduction 1 day after
the peak (see Materials and Methods). For most of the estimates of
the infected cell death rate in the literature, the target cell limited
model cannot generate a .2 log decline within 1 day after the
viral peak. This suggests that other factors not included in the
target cell limited model may be responsible for this dramatic viral
decline. We tested different models based on several possible
biological mechanisms (see below) and found that the model
shown in Eq. (1) can reproduce the viral load change observed in
the 6 ponies. The rapid viral decline after the peak is mainly due to
the combination of two factors: the decline of target cells because
of their conversion to the refractory class (wFT in Eq. 1) by IFN’s
antiviral effect, and the killing of infected epithelial cells (kIF in
Eq. 1), possibly mediated by IFN activated NK cells during the
innate immune response.
We plotted the changes of uninfected target cells (solid blue),
infected cells (solid green), refractory cells (dashed red), and total
cells (dotted black) in Figure 4. The number or percentage of
infected epithelial cells is low compared to the prediction of the
target cell limited model [20]. In contrast with the predictions of
the Saenz et al. model [19], the level of uninfected target cells
remains high (.10
10 cells) for all the ponies during the entire
infection course. The reversion of cells from the refractory to the
susceptible class (rR) prevents uninfected target cells from
decreasing to a very low level. This suggests that in addition to
target cell depletion, cytolysis of infected cells mediated by IFN
activated cells such as NK cells during the innate immune
response may be responsible for the viral decline during the early
stage of influenza virus infection.
To further test if a model that only includes the refractory class
without NK cell-mediated infected cell killing (k~0 in Eq. 1;
referred to as model 2) can explain the first rapid viral decline, we
fit model 2 to the same experimental data (dashed lines in Figure 5
for viral load and Supporting Figure S1 for IFN fold change). We
found model 2 cannot generate the rapid viral load decline after
the peak. We also tested a model assuming that IFN only reduces
the viral production rate (i.e., assuming k~0 and replacing p with
p
1zQF in Eq. (1); this is referred to as model 3) and found this model
could not generate the first rapid viral decline either and yielded
dynamics very similar to model 2 (dotted lines in Figure 5). Thus,
the cell-mediated lysis of infected cells during the innate immune
response plays a critical role in generating the first rapid viral
decline in our model. We calculated the error between modeling
predictions and experimental data (RMS) for different models.
The RMS values are given in Table 3. Model 1 generated the
smallest error for each pony.
We compared the best fits of using model 1 and model 2 by
performing an F-test , which determines which one of the two
nested models provides a better data fit from a statistical
standpoint (Materials and Methods). The results given in Table 3
show that model 1 provides significantly better fits for ponies 2 and
3 (with the p-value,0.05). For the other ponies, the F-test shows
that there is a statistical trend supporting model 1 (with the p-value
from 0.1 to 0.4). We also compared the best fits using the modified
Akaike Information Criterion (AICc) (Supporting Text S1). Model
1 is supported over model 2 for each pony (Table S4).
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Saenz et al. fits [19] because the objective functions minimized
during data fitting are different. Saenz et al. [19] incorporated the
percentage of infected cells in their fitting. We did not include this
because the data of the percentage of infected cells were from a
different study [43]. The errors listed in Table 3 and the fitted
curves (Figures 2 and 3) show that our fits improve those using the
Saenz et al. model.
Viral plateau and second peak
The phenomenon of bimodal viral titer peaks in most ponies
[16] was also observed in other studies with influenza virus
Figure 2. Model comparisons with viral load data. Best fits of Eq. (1) (solid red) and the Saenz et al. model (dashed green) to the viral load data
(filled red circles) were shown. The horizontal dashed blue line represents the detection limit of the viral titer, i.e., 100 RNA copies per ml of nasal
secretions. Data below the detection limit were plotted as 1 RNA copy per ml of nasal secretions.
doi:10.1371/journal.pcbi.1002588.g002
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PLoS Computational Biology | www.ploscompbiol.org 6 June 2012 | Volume 8 | Issue 6 | e1002588infection [44,45,46]. The target cell limited model [20] and the
Saenz et al. model [19] cannot generate bimodal virus titer peaks.
Adding the effect of IFN and a time delay in its production into the
target cell limited model was shown to be able to generate bimodal
peaks [20]. However, the fits obtained by Baccam et al. [20] using
this model did not agree well with the data. Our fits using model 1
generated an obvious bimodal behavior (Figure 2). The level of
IFN peaked around day 2 and then declined rapidly (Figure 3),
concordant with the emergence of viral plateau/second peak
(Figure 2). Thus, the viral plateau and the second viral titer peak
can be explained by the loss of the IFN-induced antiviral effect
(wFT in Eq. 1). Increased availability of susceptible cells due to
reversion from the refractory state (rR in Eq. 1) can also contribute
to the viral plateau/second peak. From our data fits we estimated
Figure 3. Model comparisons with IFN data. Best fits of Eq. (1) (solid blue) and the Saenz et al. model (dashed orange) to the IFN fold change
data (filled blue circles) were shown.
doi:10.1371/journal.pcbi.1002588.g003
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PLoS Computational Biology | www.ploscompbiol.org 7 June 2012 | Volume 8 | Issue 6 | e1002588that the rate (r) at which refractory cells (R) revert from the
refractory to the susceptible state is on average 2.6 per day. The
reversion rate is also important in preventing uninfected target
cells from decreasing to a very low level. Sensitivity tests of the
model predictions to a number of parameters, including w and r,
are given below.
Sensitivity test
We examined the sensitivity of the predicted viral load of pony 1
to several parameters, including w, r, k, and p (Figure 6). More
sensitivity tests of the predicted viral load and IFN to other
parameters and contour plots are presented in Supporting Figures
S2, S3, S4, S5, S6, S7, S8. Sensitivity tests show that the IFN’s
antiviral efficiency (w) and the reversion rate (r) are important in
generating the viral plateau and the second peak (Figure 6A, B). A
large value of w can also yield a rapid first viral decline. However,
this will eliminate the viral plateau and the second peak
(Figure 6A). Increasing the infected cell killing rate constant k
alone will decrease the first viral peak and increase the second
peak (Figure 6C). A large value of the viral production rate p
(Figure 6D) or the infection rate b (Figure S2) can achieve the first
viral peak. However, they will significantly reduce the time for the
viral titer to reach the peak. These sensitivity tests suggest that the
cell-mediated lysis of infected cells (k) and the IFN’s antiviral effect
(w) during the innate immune response are the major factors
responsible for the first rapid viral decline and subsequent viral
plateau/second peak.
Since the initial number of target cells of H3N8 virus infection
could be less than 3.5610
11 cells (T0), the estimate of total
epithelial cells in the equine respiratory tract [39], we reduced it
from T0 to 75% or 50% of T0. The simulation in which the other
parameters are assumed to be unchanged shows that a small initial
number of target cells can delay the time to reach the first viral
peak, reduce the magnitude of the peak viremia, and eliminate the
Figure 4. The changes of cell populations predicted by Eq. (1) based on the best fits. Solid blue represents susceptible cells, solid green
represents infected cells, dashed red represents cells in the refractory state, and dotted black represents the total number of cells. The curves were
zoomed in for ponies 2 and 4 to show the level of refractory cells.
doi:10.1371/journal.pcbi.1002588.g004
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PLoS Computational Biology | www.ploscompbiol.org 8 June 2012 | Volume 8 | Issue 6 | e1002588Figure 5. Best fits of different models to experimental data. Model 1 is described by Eq. (1). Model 2 is Eq. (1) with k=0, i.e., no killing of
infected cells by NK cells. Model 3 is model 2 assuming the viral production rate is p=(1zQF). The detection limit of the viral titer is 100 RNA copies
per ml of nasal secretions. Data below the detection limit were plotted as 1 RNA copy per ml of nasal secretions.
doi:10.1371/journal.pcbi.1002588.g005
Table 3. Comparisons of the best fits using different models.
Pony RMS of model 1* RMS of model 2*
Number of data
points** p-value for F-test RMS of Saenz et al. model***
1 0.695 0.951 14 0.181 1.442
2 0.651 1.061 15 ,0.05 1.873
3 0.320 0.718 14 ,0.05 1.613
4 0.768 0.953 15 0.202 1.352
5 0.618 1.027 13 0.157 1.610
6 0.695 0.845 13 0.400 1.802
*Model 1 is described by Eq. (1). Model 2 is Eq. (1) with k=0, i.e., there is no killing of infected cells by NK cells.
**We did not include data points of viral titer under the detection limit after the first undetectable data point.
***The RMS value was calculated by Eq. (2) in the Materials and Methods. These values are different from those presented in Saenz et al. [19] because the percentage of
infected cells is not included (see text).
doi:10.1371/journal.pcbi.1002588.t003
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PLoS Computational Biology | www.ploscompbiol.org 9 June 2012 | Volume 8 | Issue 6 | e1002588viral plateau (Figure S2). However, data fitting using 75% and
50% of T0 still generates good fits to the experimental data (see
Figure S2 for the fit to the viral load data of pony 1).
Discussion
The biological factors responsible for viral control during
influenza virus infection remain unclear. Earlier work [20]
suggested that the viral decline after the peak could be explained
by a limitation in the availability of target cells. However, a recent
study by Saenz et al. [19] estimated that ,5% of epithelial cells
are infected at any one time and that the total epithelial cell loss is
,30% by the end of the infection. They modified the target cell
limited model by including an IFN-induced antiviral state of
uninfected cells [19]. However, their modified model is still
essentially a target cell limited model — uninfected target cells
move to the refractory class, causing the depletion of susceptible
cells and hence the viral titer declines after reaching the peak.
Numerical simulations also confirmed this prediction (Figure 3 in
[19]). As we analytically showed in Materials and Methods, the
target cell limited model cannot generate a rapid and substantial
viral decline after the peak unless a very large death rate of
infected cells is chosen. However, only increasing the death rate of
infected cells will decrease the first peak and eliminate the viral
plateau/second peak, which is observed in all the 6 ponies. In this
paper, we developed a new model (Eq. (1)) and showed that
cytolysis of infected cells mediated by cytokines and cells such as
NK cells during the innate immune response, can explain the
rapid viral decline after peak.
During an early stage of infection, NK cell activity contributes
to a rapid termination of many virus infections, including
influenza, before the onset of the adaptive immune response
[11,47,48,49,50]. Several studies in mice have illustrated that
depletion of NK cells resulted in increased morbidity and mortality
from influenza infection [51,52,53]. In humans, severe/lethal
2009 H1N1 influenza virus infection in 3 cases was associated with
reduction of NK cells rather than effector CD8
+ T cells [54], and
influenza vaccination led to increased levels of NK cells with
activation markers CD56 and CD69 [55]. NK cells are not only
responsible for producing antiviral cytokines, but they are also
directly involved in destroying virus-infected cells via the
recognition by the natural cytotoxicity receptors (NCR) NKp46
(NCR1 in mice [6]) and NKp44 [7,8,9,10]. Gazit et al. [6] showed
that influenza virus infection was lethal in mice when the NK
receptor NCR1 was knocked out.
In our model, we assumed that the level of activated NK cells is
proportional tothat ofIFN,whoselevelsweremeasuredinthe study
[16]. There is evidence supporting that NK cells have similar
dynamics to IFN and virus during influenza virus infection. For
example, an experimental study on murine influenza virus infection
[56] showed that the effector cells with the properties of NK cells
had very similar dynamics to the IFN level changes, i.e., peaked at
1–2dayspost-infectionand decreasedtolowlevelsbyday6.Inmice
that were inoculated intranasally with the mouse-adapted strain of
human influenzaA/PR/8/34(H1N1)virus,the timing ofviral peak
and subsequent decline was consistent with that of NK cell-
mediated cytolysis [57]. Another study [58] also showed that the
peakofNKcellsoccurredwithinthefirstseveraldaysafterinfluenza
virus infection in mice, consistent with the timing of IFN
production. In addition to the killing by IFN activated NK cells,
high expression of cytokines during the innate immune response
may also lead to infected cell death [34]. For example, influenza A
virus-stimulated apoptosis was shown to be enhanced by IFN a/b
and by increased expression of the antiviral protein PKR [35].
Figure 6. Sensitivity tests of the predicted viral load of pony 1 to model parameters. The parameter in the legend was varied (10-fold
larger or smaller than the estimate in Table 2) while the remaining parameters were fixed and chosen from Table 2.
doi:10.1371/journal.pcbi.1002588.g006
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tosis-inducing ligand) also plays an important role in promoting
epithelial cell apoptosis [33].
We used IFN as a proxy of the innate immune response to
model the cell-mediated lysis of infected epithelial cells and the
antiviral effect. This may not be accurate because a number of
other cytokines are involved in the innate immune response.
Dendritic cells (DCs) and macrophages produce large amounts of
antiviral and immunostimulatory cytokines in response to influ-
enza virus infection [2,4,59,60,61]. We assumed that IFN is
secreted by epithelial cells once they are infected. Other cells, such
as monocytes, macrophages, and plasmacytoid DCs, can also
contribute to IFN production [4,37,62]. Further, there may exist a
time delay in IFN production, as observed in pony 1 (Figure 3) in
which viral titer/infected cells peaked at day 2 post-infection while
IFN peaked at day 3 post-infection. A similar time lag was
observed in mice with influenza virus infection [63]. Moltedo et al.
[63] showed that the initiation of lung inflammation (generation of
IFNs, cytokines, chemokines, etc) did not begin until almost 2 days
after infection, when virus replication reached its peak. This delay
may be mediated by the influenza-encoded NS1 protein [63],
which can act to block IFN production in influenza infected cells
[48,64,65]. The burst of IFN production after day 2 might be
explained by activation of plasmacytoid DCs or other uninfected
cells in the lung, which are activated to a degree that correlates
with viral titer or number of infected cells. Future comprehensive
models may wish to take macrophages, DCs and other cytokines
into account. However, more complicated models should be
accompanied with appropriate data for model verification.
After the rapid post-peak decline of viral titer, we observed a
plateau phase and/or the second viral peak. Although a number of
models have been developed to study within-host influenza virus
dynamics, very few models can generate the second peak. As the
innate immune response weakens (Figure 3 shows that a rapid IFN
decay was observed in all ponies even when the viral load was still
high), the killing of infected cells (kIF) lapses in our model. Thus,
the level of infected cells can remain unchanged for a while or
even increase. This can explain the viral plateau and the second
viral increase.
Another factor leading to the second peak is the augmented
availability of target cells. The rapid IFN decay significantly
reduces the conversion of susceptible cells to the refractory class.
Because cells are most likely unable to maintain the antiviral state
for a long time without continued IFN signaling, those cells that
are already in the refractory class will revert back to the susceptible
state and become the target of virus infection again. This will
enhance the viral production. Some other factors may also
contribute to the second peak. For example, when virus spreads to
a previously uninvolved site in the lung or respiratory tract as
discussed in [20], viral infection and production will increase and
may lead to a second viral load increase.
After reaching the second peak around day 6 post-infection, the
viral titer underwent a rapid second viral decline to below the
detection limit. We showed that this second viral decline can be
generated by the emergence of an adaptive immune response
(Figure 2), which usually arises 4 to 7 days post-infection [11].
Without introducing an adaptive immune response in the model,
the virus will not be cleared in ponies with a plateau/second peak.
Because CD8
+ T cell were not measured for these ponies, we
assumed an increasing death rate of infected epithelial cells, dA,
after the second peak. We have also examined a model with an
explicit adaptive immune response by adding another variable X,
representing cytotoxic T lymphocytes (CTL), with dX/dt=rX,
where r is the net expansion rate. We assumed the CTL-mediated
killing of infected cells is 2kXI in addition to dII in the model. In
order for the adaptive immune response to remain at a very low
level during the first several days, r should be very small. However,
such a low-level adaptive immune response cannot generate the
rapid second viral decline. This problem can be resolved by using
a larger r and a time delay for the emergence of the adaptive
immune response. However, this method is almost the same as
what we did in the main text: increasing the death rate of infected
cells several days after infection.
In addition to CD8
+ T cells, antibodies neutralizing free virions
may also be involved in viral clearance. Increasing either the
infected cell death rate d, as shown in our study, or the viral
clearance rate c can generate the same second viral decline to
below the detection limit. Thus, from the comparison between
model predictions and the data, we cannot determine if the viral
clearance is mainly caused by CD8
+ T cells or neutralizing
antibodies. However, in the experiment [16] from which we
studied the data, no anti-influenza antibodies were detected by the
SRH assay 7 days post-challenge in any of the ponies. Low levels
of antibodies were detected by ELISA on day 7 for 3 of the 6
ponies. Although such antibodies may exist at low levels before day
7, they may not be the major factor responsible for viral clearance
because the infection was already resolved by day 7 in ponies 5
and 6. Likewise, we cannot estimate the duration of the eclipse
phase in which infected cells have not started to produce virions
because the model with and without an eclipse phase both fit the
experimental data well (Supporting Text S1, Table S1, Table S2,
Figures S9, and S10).
Although target cells are not depleted, we predict a decline of
target cells as well as the total number of epithelial cells during
infection (Figure 4). The reason for the decline is that we did not
include generation/proliferation of epithelial cells. This is not
important for the short time period of infection we studied.
Consistent with the other studies [19,20,21], including the
regeneration of target epithelial cells in our model does not
improve the fits of the model to the data set. This is also supported
by the observation in humans that regenerating respiratory
epithelium cells appeared only in 3 out of 14 subjects after 5–14
days post-infection [66], whereas virus infection is usually resolved
within 7–10 days [67]. Once the virus is cleared, generation/
proliferation will increase epithelial cells to the pre-infection level.
In summary, by fitting mathematical models to the viral load
and IFN data we illustrate that both the innate and adaptive
immune responses are needed to explain the viral load change
during influenza virus infection. The first post-peak viral decline
(about 2 to 4 logs within 1 day) can be explained by the lysis of
infected epithelial cells, mediated by cytokines and cells such as
NK cells, during the innate immune response. The subsequent
viral plateau/second peak is generated in our model by the loss of
the IFN-induced antiviral effect and the increased availability of
target cells as cells lose their antiviral state. An adaptive immune
response is needed in our model to explain the eventual viral
clearance. A detailed and quantitative study of the within-host
dynamics of virus, cells, and cytokines may provide more
information for future research in influenza pathogenesis, treat-
ment, and vaccination.
Supporting Information
Figure S1 Best fits of different models to the IFN data.
Model 1 is described by Eq. (1). Model 2 is Eq. (1) with k=0, i.e.,
no killing of infected cells by NK cells. Model 3 is model 2
assuming the viral production rate is p=(1zQF).
(TIFF)
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parameters. The first four rows: sensitivity tests of the predicted
viral load of pony 1 to model parameters (Eq. (1)). The parameter
in the legend was varied while the remaining parameters were
fixed and chosen from Table 2. The fifth row: best fits of Eq. (1)
assuming the initial number of target cells is 75% or 50% of
3.5610
11 cells to the viral load data. The best-fit parameters are
shown in Table S3.
(TIF)
Figure S3 Sensitivity tests of predicted interferon level
to parameters. The parameter in the legend was varied while
the remaining parameters were fixed and chosen from Table 2.
(TIF)
Figure S4 Contour plots of the viral load as a function of
the indicated parameter and time. On the right side of each
contour plot there is a color scale in which different colors
represent different viral loads (in the log scale).
(TIF)
Figure S5 Contour plots of interferon as a function of
the indicated parameters and time.
(TIF)
Figure S6 Contour plots of the viral load peak as a
function of the indicated parameters.
(TIF)
Figure S7 Contour plots of the interferon peak as a
function of the indicated parameters.
(TIF)
Figure S8 Contour plots of the viral load as a function of
the indicated parameters and time.
(TIF)
Figure S9 Best fits of the eclipse model to the viral load
data. The horizontal dashed blue line represents the detection
limit of the viral titer, i.e., 100 RNA copies per ml of nasal
secretions. Data below the detection limit were plotted as 1 RNA
copy per ml of nasal secretions.
(TIF)
Figure S10 Best fits of the eclipse model to the IFN data.
(TIF)
Table S1 Parameter values of the best fits of the eclipse
model to experimental data.
(PDF)
Table S2 Comparisons of the best fits using different
models.
(PDF)
Table S3 Parameter values of the best fits of Eq. (1)
with reduced T0 to the data of pony 1.
(PDF)
Table S4 Comparisons of the best fits using AIC.
(PDF)
Text S1 The model with an eclipse phase.
(PDF)
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